MOG and Alzheimer disease: The head MRI of patients #3–#5 suggested the possible presence of demyelinating lesions, and several head MRI examinations after immunotherapy did not show any shrinking of the foci, which did not conform to the clinical manifestations and prognosis of MOG-AD.